Discovering a New Cancer Killer

Dr. Marek Los (2004 Research Grant) 

Marek Los’ research story is classic. While studying the process of cell death he stumbled upon a protein called apoptin which kills cancer cells while sparing healthy cells. Apoptin is sneaky. Cancer cells use certain pathways to keep themselves alive. Apoptin hijacks these pathways and redirects them to kill cancer cells. Even better, apoptin seems to work especially well in hormone refractory prostate cancer – a stage of cancer that is nearly impossible to treat. More research is needed but Los’ work may lead to new treatment options.

Prostate Cancer Awareness Month

Donate Now!


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive